LXEO · Lexeo Therapeutics, Inc.
AI read · Good for LXEO
The AI's read
These findings may help Lexeo move LX2020 toward a larger study for a serious heart condition. The FDA is open to using one heart-rhythm measure in that study, but its final plan still needs further discussion.